Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
6C1:FRA
CytomX Therapeutics Inc
€3,41
-1,22%
(-0,042) 1D
30 Apr., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6C1...
Open
€3,41
High
€3,41
Low
€3,41
Mkt. cap
903,62 m
Avg. vol.
410,00
Volume
0,00
52-wk high
€6,97
52-wk low
€0,56
No. of employees
69
News stories
From sources across the web
About CytomX Therapeutics Inc
CEO-
Employees69
Founded2008
HeadquartersSouth San Francisco, Kalifornië, Verenigde State van Amerika
Sector-
Websitecytomx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
50,92 m
18,66 m
5,96 m
663,00 k
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
18,87 m
13,32 m
15,30 m
19,54 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,43 m
6,62 m
6,43 m
6,26 m
Operating expense
28,30 m
19,94 m
21,73 m
25,80 m
Total operating expenses
28,30 m
19,94 m
21,73 m
25,80 m
Operating income
22,62 m
-1,29 m
-15,77 m
-25,13 m
Other non operating income
-
-
-
-
EBT including unusual items
23,59 m
-91,00 k
-14,17 m
-26,46 m
EBT excluding unusual items
23,59 m
-91,00 k
-14,17 m
-23,66 m
Income tax expense
62,00 k
63,00 k
58,00 k
54,00 k
Effective tax rate
0,26%
-69,23%
-0,41%
-0,20%
Other operating expenses
-
-
-
-
Net income
23,52 m
-154,00 k
-14,23 m
-26,51 m
Net profit margin
46,20%
-0,83%
-238,62%
-3 998,49%
Earnings per share
0,27
-
-0,09
-0,22
Interest and investment income
955,00 k
1,18 m
1,59 m
1,48 m
Interest expense
-
-
-
-
Net interest expenses
955,00 k
1,18 m
1,59 m
1,48 m
Depreciation and amortization charges
-
-
-
-
EBITDA
23,01 m
-939,00 k
-15,63 m
-24,62 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer